Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF96.7.
  • 活动
  • 新闻
  • 行业洞察
  • 账户
Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
Industry Events

News

Categories

  • 最新
  • 中国与金砖国家+
  • 人工智能与科技
  • 供应链
  • 农业
  • 创业与风险投资
  • 医疗健康
  • 半导体
  • 国防
  • 机器人
  • 网络安全
  • 能源与出行
  • 金融科技

Select a category to explore the latest industry reporting.

NewsTuesday, 25 August 2026
Newsletter subscribe · Free
  • 最新
  • 人工智能与科技
  • 网络安全
  • 半导体
  • 机器人
  • 金融科技
  • 能源与出行
  • 国防
  • 医疗健康
  • 供应链
  • 创业与风险投资
  • 中国与金砖国家+
  • 农业

新闻

医疗健康

来自塑造行业的会议、展会和峰会的 医疗健康 领域最新新闻、公告和分析。

该分类的最新新闻

STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection (opens original source in a new tab)
STAT News

STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.

(opens original source in a new tab)
Adam Feuerstein·20 August 2026
Reduce protein to increase longevity? Nutrition experts say that’s a bad idea (opens original source in a new tab)
STAT News

Reduce protein to increase longevity? Nutrition experts say that’s a bad idea

Reducing protein intake could increase human longevity, researchers recently suggested. That's a bad idea, for several reasons, experts say.

(opens original source in a new tab)
Lauren Chan·20 August 2026
Can reclassifying muscle dysmorphia unlock better care for boys and men? (opens original source in a new tab)
STAT News

Can reclassifying muscle dysmorphia unlock better care for boys and men?

Males make up about a third of the population struggling with eating disorders in the United States. While these conditions often start during the teen years, by some estimates, as…

(opens original source in a new tab)
Ashleigh N. DeLuca·20 August 2026
STAT+: How health systems are embracing chatbots to query and summarize patient records (opens original source in a new tab)
STAT News

STAT+: How health systems are embracing chatbots to query and summarize patient records

Several large health systems are rolling out AI chatbots to query patient records, because they can save time and increase diagnostic accuracy.

(opens original source in a new tab)
Katie Palmer·20 August 2026
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study (opens original source in a new tab)
STAT News

Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study

“Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has Duchenne muscular dystrophy.

(opens original source in a new tab)
Mindy Leffler·20 August 2026
STAT+: How Trump loyalist Heidi Overton became the president’s pick to run the FDA (opens original source in a new tab)
STAT News

STAT+: How Trump loyalist Heidi Overton became the president’s pick to run the FDA

If she wins confirmation as FDA commissioner, Heidi Overton will face plenty of big challenges.

(opens original source in a new tab)
Chelsea Cirruzzo and Daniel Payne·19 August 2026
STAT+: New CDC director tells staff she is prepared to speak ‘truth to power’ (opens original source in a new tab)
STAT News

STAT+: New CDC director tells staff she is prepared to speak ‘truth to power’

Then new CDC director told staff she is “very comfortable and very confident ... [in] speaking truth to power.”

(opens original source in a new tab)
Daniel Payne and Helen Branswell·19 August 2026
Trust in science: A new STAT initiative (opens original source in a new tab)
STAT News

Trust in science: A new STAT initiative

Dear Readers, When we launched STAT more than a decade ago, our mission statement promised that we would deliver "trusted, tough-minded journalism.'' Little did we know that trust would be…

(opens original source in a new tab)
Rick Berke·19 August 2026
STAT+: Experts scrutinize Huidagene’s disclosures after patient death (opens original source in a new tab)
STAT News

STAT+: Experts scrutinize Huidagene’s disclosures after patient death

Merck and Moderna's mRNA cancer vaccine, an expected nominee to lead the FDA, and more biotech news from The Readout

(opens original source in a new tab)
Elaine Chen·19 August 2026
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval (opens original source in a new tab)
STAT News

STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval

A Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.

(opens original source in a new tab)
Andrew Joseph·19 August 2026
STAT+: American Cancer Society cancels alcohol industry fundraiser (opens original source in a new tab)
STAT News

STAT+: American Cancer Society cancels alcohol industry fundraiser

The American Cancer Society had an optics problem: its annual Wine and Spirits Industry's Gala. It decided to do something about it.

(opens original source in a new tab)
Isabella Cueto·19 August 2026
STAT+: Brain organoids, kept alive more than five years, matured like human brains (opens original source in a new tab)
STAT News

STAT+: Brain organoids, kept alive more than five years, matured like human brains

Brain organoids kept alive more than five years continued to develop and mature, and showed molecular and genetic signatures like those of human brains.

(opens original source in a new tab)
Megan Molteni·19 August 2026

最多阅读

  1. 01

    STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

  2. 02

    Reduce protein to increase longevity? Nutrition experts say that’s a bad idea

  3. 03

    Can reclassifying muscle dysmorphia unlock better care for boys and men?

  4. 04

    STAT+: How health systems are embracing chatbots to query and summarize patient records

  5. 05

    Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study

Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Next
  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF96.7.

每周五送达的行业活动一周要闻。

一封简短的邮件。汇集塑造全球商业的展会、会议和峰会的头条新闻。没有废话,没有垃圾邮件,随时可取消订阅。